Pulmonary Vein Isolation with the Cryoballoon Technique: feasibility, Procedural Outcomes and Adoption in the Real World: Data from One Shot technologies TO Pulmonary vein isolation (1STOP) project

Pacing Clinical Electrophysiology

21 November Nov 2016 10 months ago
  • Tondo C

Catheter ablation (CA) is recommended for patients with drug refractory symptomatic atrial fibrillation (AF). "One Shot" catheters have been introduced to simplify CA and cryoballoon-ablation (CBA) is spreading rapidly. Few real-world data are available on standard clinical practice, mainly from single center experience. The Authors aimed to evaluate clinical settings, demographics and acute procedural outcomes in a large cohort of patients treated with CBA.

In that which constitutes the largest experience of CBA in the treatment of AF that also describes the adoption curve of this relatively recent technology, CBA showed an excellent safety profile when performed in a large real-world clinical setting, with satisfactory acute success rate and, on average, short procedural times.


Reference

  1. Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, Sciarra L, Senatore G, Catanzariti D, Leoni L, Landolina M, Delise P, Iacopino S, Pieragnoli P, Arena G; 1STOP Clinical Service centres. Pulmonary Vein Isolation with the Cryoballoon Technique: feasibility, Procedural Outcomes and Adoption in the Real World: Data from One Shot technologies TO Pulmonary vein isolation (1STOP) project. Pacing Clin Electrophysiol 2016 Nov 10 [Epub ahead of print] Go to PubMed